本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Immix Biopharma, Inc

2.09
-0.0550-2.56%
盘后2.090.00000.00%16:05 EDT
成交量:4.75万
成交额:10.08万
市值:5,793.92万
市盈率:-2.74
高:2.22
开:2.10
低:2.04
收:2.15
数据加载中...
2022/02/11

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/09

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/01/25

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2022/01/19

重要事件披露

8-K - Current report
2022/01/12

重要事件披露

8-K - Current report
2022/01/03

重要事件披露

8-K - Current report
2021/12/28

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/12/20

重要事件披露

8-K - Current report
2021/12/13

SEC问询函

CORRESP [Cover] - Correspondence
2021/12/13

SEC问询函

CORRESP [Cover] - Correspondence
2021/12/01

[补充]招股说明书

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2021/11/04

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2021/10/28

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2021/10/15

SEC问询函

CORRESP [Cover] - Correspondence
2021/10/15

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2021/10/06

SEC问询函

CORRESP [Cover] - Correspondence
2021/10/06

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2021/09/17

招股说明书

S-1 - General form for registration of securities under the Securities Act of 1933
2021/09/16

SEC问询函

CORRESP [Cover] - Correspondence